Tango Therapeutics, Inc. (TNGX) has disclosed a new risk, in the Cyber Security category.
Tango Therapeutics, Inc. faces significant risks with the integration of artificial intelligence (AI) into its operations, particularly with security threats to confidential and proprietary information. The company’s use of generative AI tools, as well as those used by its vendors, could lead to breaches and a loss of intellectual property, potentially damaging its reputation and the public’s trust in its security measures. Moreover, the impending EU Artificial Intelligence Act may impose rigorous ethical and regulatory standards, increasing the burden and cost of compliance. Tango Therapeutics, Inc. must navigate these challenges carefully to protect its business interests and maintain its competitive edge in a rapidly evolving technological landscape.
The average TNGX stock price target is $17.00, implying 102.62% upside potential.
To learn more about Tango Therapeutics, Inc.’s risk factors, click here.
